Welcome to touchPODCAST where you can listen and learn from our expert faculty, hand-picked from the Touch Medical Media family of independent medical websites. Educating physicians on a fully global scale since 2005! We make positive changes to clinical practice, with the ultimate objective of improving patient and community health. Working alongside leading medical experts, societies and industry, our mission is to provide practical, expert opinions to support best practices for busy Healthcare Professionals globally, by translating published data into easily digestible and timely updates Home of: - touchONCOLOGY - touchENDOCRINOLOGY - touchOPHTHALMOLOGY - touchNEUROLOGY - touchCARDIOLOGY - touchINFECTIOUSDISEASES - touchIMMUNOLOGY - touchRESPIRATORY - touchHAEMATOLOGY - touchDERMATOLOGY This information is intended for use by licensed Healthcare Professionals (HCPs). It should not be considered medical advice, diagnosis, or treatment recommendations.
Episodes
Thursday Aug 10, 2023
Thursday Aug 10, 2023
touchEXPERT OPINIONS for touchCARDIOLOGY
Leading experts share their insights on the impact of intracerebral haemorrhage (ICH) in patients receiving direct oral anticoagulants (DOACs), DOAC-ICH reversal agents and optimizing treatment outcomes.
The experts:
- Prof. Hanne Christensen, University of Copenhagen, Denmark
- Prof. Thorsten Steiner, The Clinical Centre in Frankfurt Höchst, Frankfurt, Germany
- Dr Truman Milling, The University of Texas at Austin, TX, USA
This touchPODCAST is for HCPs only.
This activity is funded by an independent medical education grant from AstraZeneca. This activity is jointly provided by USF Health and touchIME.
For further information visit
www.touchcardio.com
Thursday Aug 10, 2023
Thursday Aug 10, 2023
touchEXPERT OPINIONS for touchNEUROLOGY
Leading experts share their insights on the impact of intracerebral haemorrhage (ICH) in patients receiving direct oral anticoagulants (DOACs), DOAC-ICH reversal agents and optimizing treatment outcomes.
The experts:
- Prof. Hanne Christensen, University of Copenhagen, Denmark
- Prof. Thorsten Steiner, The Clinical Centre in Frankfurt Höchst, Frankfurt, Germany
- Dr Truman Milling, The University of Texas at Austin, TX, USA
This touchPODCAST is for HCPs only.
This activity is funded by an independent medical education grant from AstraZeneca. This activity is jointly provided by USF Health and touchIME.
For further information visit:
www.touchneurology.com
Wednesday Aug 09, 2023
Wednesday Aug 09, 2023
touchMDT for touchONCOLOGY
Listen to key experts from a multidisciplinary team discuss the case-based implementation of
immune checkpoint inhibitors in endometrial cancer through shared decision making.
The multidisciplinary team:
- Gynaecological oncologist: Prof. Christian Marth, Innsbruck, Austria
- Medical oncologist: Dr Ilaria Colombo, Bellinzona, Switzerland
This touchPODCAST is for HCPs only.
This activity is funded by an unrestricted independent medical educational grant from GlaxoSmithKline. This activity is provided by touchIME.
For further information visit our website:
https://touchoncology.com/education/mdt-for-ici-in-ec/
Wednesday Aug 09, 2023
Wednesday Aug 09, 2023
touchMDT for touchONCOLOGY
Listen to key experts from a multidisciplinary team discuss key considerations in the management of immune-related adverse events with immune checkpoint inhibitors in advanced or recurrent endometrial cancer
The multidisciplinary team:
- Gynaecological oncologist: Prof. Christian Marth, Innsbruck, Austria
- Medical oncologist: Dr Ilaria Colombo, Bellinzona, Switzerland
- Pathologist: Dr Tjalling Bosse, Leiden, Netherlands
This touchPODCAST is for HCPs only.
This activity is funded by an unrestricted independent medical educational grant from GlaxoSmithKline. This activity is provided by touchIME.
For further information visit our website:
https://touchoncology.com/education/mdt-for-ici-in-ec/
Wednesday Aug 09, 2023
Wednesday Aug 09, 2023
touchMDT for touchONCOLOGY
Listen to key experts from a multidisciplinary team discuss improving outcomes with immune checkpoint inhibitors in advanced or recurrent endometrial cancer.
The multidisciplinary team:
- Gynaecological oncologist: Prof. Christian Marth, Innsbruck, Austria
- Medical oncologist: Dr Ilaria Colombo, Bellinzona, Switzerland
This touchPODCAST is for HCPs only.
This activity is funded by an unrestricted independent medical educational grant from GlaxoSmithKline. This activity is provided by touchIME.
For further information visit our website:
Monday Jul 31, 2023
Monday Jul 31, 2023
touchIN CONVERSATION for touchHAEMATOLOGY
Listen to Prof. John Mascarenhas (Icahn School of Medicine at Mount Sinai, New York, NY, USA) in conversation with Dr Raajit Rampal (Memorial Sloan Kettering Cancer Center, New York, NY, USA) on how to optimize the use of JAK inhibitors for patients with myelofibrosis.
They respond to questions submitted by the HCP audience and provide expert insights on:
- The key considerations when selecting a first-line JAK inhibitor
- How to best manage side effects associated with JAK inhibitors
- The treatment options following failure on a first-line JAK inhibitor
This touchPODCAST is for HCPs only.
This activity is funded by an unrestricted independent medical education grant from Bristol Myers Squibb. This activity is jointly provided by USF Health and touchIME.
For further information visit our website:
https://touchhaematologyime.org/in-conversation-jak-inhibition-in-myelofibrosis
Monday Jul 31, 2023
Monday Jul 31, 2023
touchIN CONVERSATION for touchONCOLOGY
Listen to Prof. John Mascarenhas (Icahn School of Medicine at Mount Sinai, New York, NY, USA) in conversation with Dr Raajit Rampal (Memorial Sloan Kettering Cancer Center, New York, NY, USA) on how to optimize the use of JAK inhibitors for patients with myelofibrosis.
They respond to questions submitted by the HCP audience and provide expert insights on:
- The key considerations when selecting a first-line JAK inhibitor
How to best manage side effects associated with JAK inhibitors
The treatment options following failure on a first-line JAK inhibitor
This touchPODCAST is for HCPs only.
This activity is funded by an unrestricted independent medical education grant from Bristol Myers Squibb. This activity is jointly provided by USF Health and touchIME.
For further information visit our website:
https://touchoncologyime.org/in-conversation-jak-inhibition-in-myelofibrosis
Monday Jul 31, 2023
Monday Jul 31, 2023
|
touchPANEL DISCUSSION for touchONCOLOGY Listen to a panel of leading experts discuss the importance of HPV vaccination in preventing HPV-associated cancers, World Health Organization guidance on vaccine eligibility and scheduling, as well as strategies to improve HPV vaccination uptake. The experts:
This touchPODCAST is for HCPs only. This activity is funded by an independent medical education grant from Merck & Co., Inc. and is jointly provided by USF Health and touchIME. For further information visit: touchONCOLOGY |
Monday Jul 31, 2023
Monday Jul 31, 2023
touchPANEL DISCUSSION for touchINFECTIOUS DISEASES
Listen to a panel of leading experts discuss the importance of HPV vaccination in preventing HPV-associated cancers, World Health Organization guidance on vaccine eligibility and scheduling, as well as strategies to improve HPV vaccination uptake.
The experts:
- Prof. Lynette Denny GCOB (Silver), University of Cape Town, Cape Town, South Africa,
- Prof. Eduardo Franco OC, McGill University, Montreal, Canada,
- Prof. Daniel Kelly OBE, European Cancer Organisation, HPV Action Network, Cardiff, UK
This touchPODCAST is for HCPs only.
This activity is funded by an independent medical education grant from Merck & Co., Inc. and is jointly provided by USF Health and touchIME.
For further information visit: touchINFECTIOUS DISEASES
Wednesday Jul 26, 2023
Wednesday Jul 26, 2023
touchEXPERT OPINIONS for touchONCOLOGY
Listen to three leading experts provide their insights on detection methods for HER2 amplification, as well as the clinical efficacy data for guideline-recommended HER2-targeted therapies and emerging HER2-targeted therapies for patients with metastatic colorectal cancer.
The experts
- Dr Andrew Wotherspoon - Royal Marsden Hospital, London, UK;
- Dr Andrea Cercek - Memorial Sloan Kettering Cancer Center, New York, NY, USA;
- Dr Elena Elez - Vall d'Hebron University Hospital, Barcelona, Spain;
This touchPODCAST is for HCPs only.
This activity is funded by an independent medical educational grant from Seagen Inc., and is jointly provided by USF Health and touchIME.
For further information visit our website: https://touchoncologyime.org/fulfilling_the_potential_of_her2_targeting_in_crc/